David Fournier

Practice Areas

Intellectual Property Law

Patent Prosecution & Portfolio Counseling

Biotechnology & Pharmaceutical

Cannabis Law

Career

David Fournier, firmwide Patent Prosecution & Portfolio Counseling practice chair, is an intellectual property partner with 20 years of life sciences experience. Prior to becoming an attorney, Dave spent several years working in clinical research and as a patent agent with Pfizer and its legacy companies, where he gained experience monitoring clinical trials and ultimately was responsible for the development and implementation of product lifecycle management strategies for a variety of key products. Through that industry experience, Dave gained valuable insight into drug development and product lifecycle management strategies.

Dave primarily helps start-up and middle–market pharmaceutical, biotech and medical technology companies build, enforce, and monetize their global patent portfolios. Dave routinely assists his clients with IP assessments, acquisitions and divestitures, patent licensing matters as well as non-infringement and validity opinions, freedom to operate analyses, and invention records management programs.

Dave concentrates on pharmaceutical, biologic, medical device, and consumer product patent matters, with particular emphasis on global product exclusivity planning, strategic patent portfolio development, and client counseling under the Drug Price Competition and Patent Term Restoration (Hatch-Waxman) Act, relating to pharmaceutical products, and the Public Health Service Act and the Biologics Price Competition and Innovation Act, relating to biologic therapies.